Loading clinical trials...
Loading clinical trials...
A Multi-national, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel Study Comparing the Efficacy and Safety of Valsartan/Amlodipine 80/5 mg to Amlodipine 5 mg Alone Once Daily in Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Amlodipine 5 mg Monotherapy
Conditions
Interventions
Valsartan/amlodipine 80/5 mg
Amlodipine 5 mg
Locations
12
China
China-Japan Friendship Hospital
Beijing, China
People's hospital affiliated Beijing University
Beijing, China
The third Xiangya hospital of central south University
Changsha, China
The first hospital affiliated the third military Medical University
Chongqing, China
The third hospital affiliated the third military Medical University
Chongqing, China
Union hospital affiliated Fujian medical University
Fuzhou, China
Start Date
January 1, 2007
Primary Completion Date
November 1, 2007
Completion Date
November 1, 2007
Last Updated
April 29, 2011
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Novartis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions